EC proposal on new clinical trial rules not expected until late 2011
This article was originally published in Scrip
The European Commission says that the consultation exercise on the review of the EU clinical trials directive has yielded some useful information on the shortcomings of the legislation and that it is now looking at the various policy options for tackling them.
You may also be interested in...
A new project devised by Pfizer and the Wellcome Trust aims to tackle antimicrobial resistance (AMR) in four sub-Saharan African countries by using real world data to track resistance patterns and allow patients to be treated more successfully. Wellcome’s Gemma Buckland-Merrett explains how the project will work and how it could help other industry partners and governments to generate valuable data in the fight against AMR.
As the US snaps up most supplies of remdesivir, the EU says it is committed to ensuring global access to coronavirus medicines and international donors have been asked to pledge more money to pay for vaccines, medicines and tests. The past week has also seen some ups and downs for trials of various products for the treatment or prevention of COVID-19.
A second wave of COVID-19 infection later this year would put even greater pressure on drugs used in patients hospitalized with serious respiratory problems, a new report warns.